Deprescribing intervention

BEHAVIORAL5 trials

Sponsors

Bright Vision Hospital, Duke University, VA Office of Research and Development, The University of Texas Health Science Center, Houston, Odense University Hospital

Conditions

Adverse Drug ReactionDeprescribingFrail ElderlyGeriatric AssessmentKidney Failure, ChronicPatient-centered CarePolypharmacyQuality of Life

Unknown Phase

Deprescribing of Symptomatic Medications in Rehabilitative or Subacute Care Patients

Bright Vision HospitalAdverse Drug Reaction, Polypharmacy

Start: 2016-04-05End: 2018-01-31Updated: 2017-11-28

Deprescribing for Older Dialysis Patients

CompletedNCT03631290

Duke UniversityKidney Failure, Chronic

Start: 2022-03-09End: 2023-12-13Updated: 2025-02-03

Drug Reduction in Older Patients: The DROP Trial

CompletedNCT03722017

VA Office of Research and DevelopmentFrail Elderly, Geriatric Assessment, Patient-centered Care +1

Start: 2019-10-07End: 2023-03-31Updated: 2024-08-27

Reducing Costs by Deprescribing Medications

CompletedNCT04553107

The University of Texas Health Science Center, HoustonAdverse Drug Reaction, Deprescribing, Polypharmacy

Start: 2019-12-09End: 2022-06-01Updated: 2022-11-22

Medication Use and Quality of Life Among Older People

Active, not recruitingNCT05123313

Odense University HospitalQuality of Life, Reduction, Harm

Start: 2021-10-26End: 2025-12-31Target: 188Updated: 2025-08-08

Related Papers

Effectiveness and feasibility of deprescribing of symptomatic medications in a Singapore rehabilitation hospital

Proceedings of Singapore Healthcare2018-07-108 citations